Using pulmonary age to help people quit smoking
Effectiveness of the Evaluation and Communication of "Pulmonary Age" as Help for Smoking Cessation: a Cluster Randomized Essay
This study tests if sharing a person's "pulmonary age" can help smokers aged 25 and older quit smoking better than standard care alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 800 (estimated) |
| Ages | 25 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT04276116 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of communicating a patient's 'pulmonary age' as a motivational tool for smoking cessation. It involves a cluster randomized controlled design with two groups: one receiving pulmonary age assessments and the other receiving standard care without this information. Patients aged 25 and older who have been smoking for over a year will participate, with assessments conducted at the start, six months, and twelve months after inclusion. The primary outcome is the rate of smoking cessation at six months, verified through exhaled carbon monoxide measurements.
Who should consider this trial
Good fit: Ideal candidates are adults aged 25 and older who have been smoking for at least one year.
Not a fit: Patients with known respiratory illnesses or those who are pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance smoking cessation rates by providing patients with a tangible measure of their lung health.
How similar studies have performed: While few studies have explored the use of pulmonary age in smoking cessation, existing research has shown mixed results, indicating this approach may be novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient 25 years of age or older * Smoker for a year or more * Patient giving informed and written consent to participate in the study * Patient affiliated to a social security scheme Exclusion Criteria: * Known respiratory illness, chronic or acute in progress or less than 3 weeks old (BPCO, asthma, other respiratory disease * Refusal * Myocardial infarction less than a year * Chest or abdominal pain preventing or limiting completion of the forced exhalation maneuver necessary for evaluation of "pulmonary age", whatever the cause * Oral or facial pain exacerbated by the mouthing of the mouthpiece * Stress urinary incontinence * Mental confusion or dementia * Pregnant or breastfeeding woman * Major protected * Do not understand french
Where this trial is running
Paris
- Hôpital Saint Antoine — Paris, France (Recruiting)
Study contacts
- Study coordinator: Jean Sebastien Cadwallader, MD
- Email: jscadwallader@wanadoo.fr
- Phone: +33 1 48 11 22 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.